Clinical Trial Update: Nicotinic Acid Composition of HDL and Arterial Endothelium Function in Premature Coronary Heart Disease and High HDL [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating how nicotinic acid affects HDL composition and arterial endothelial function in individuals with dyslipidemia and premature coronary ar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Hyperlipidemia

Drugs mentioned

• Niacin (nicotinic acid)

Snippet

Sponsor: Xavier Pinto Sala | Conditions: Dyslipidemias | Phase 4 | Status: TERMINATED